Cover Image

Onchocerciasis-associated epilepsy and biomarkers.

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Robert Colebunders (Author), Amber Hadermann (Author), Alfred K Njamnshi (Author), Bruno P Mmbando (Author), Olivia Kamoen (Author), Joseph Nelson Siewe Fodjo (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Onchocerciasis-associated epilepsy and biomarkers
by: Robert Colebunders, et al.
Published: (2024)

The onchocerciasis hypothesis of nodding syndrome.
by: Robert Colebunders, et al.
Published: (2023)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
by: Sarah O'Neill, et al.
Published: (2019)

Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
by: Robert Colebunders, et al.
Published: (2024)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania
by: Christoph Kaiser, et al.
Published: (2019)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
by: Robert Colebunders, et al.
Published: (2019)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2018)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
by: Nolbert Gumisiriza, et al.
Published: (2020)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
by: Robert Colebunders, et al.
Published: (2019)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Report of the first international workshop on onchocerciasis-associated epilepsy
by: Robert Colebunders, et al.
Published: (2018)

Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness.
by: Samit Bhattacharyya, et al.
Published: (2023)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
by: Michel Mandro, et al.
Published: (2020)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
by: Natalie V. S. Vinkeles Melchers, et al.
Published: (2018)

Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation.
by: Robert Colebunders, et al.
Published: (2021)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
by: Housseini Dolo, et al.
Published: (2018)

In pursuit of a cure: The plural therapeutic landscape of onchocerciasis-associated epilepsy in Cameroon - A mixed methods study.
by: Maya Ronse, et al.
Published: (2021)

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
by: Bruno P. Mmbando, et al.
Published: (2018)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2023)

Adherence to COVID-19 preventive measures in Sub-Saharan Africa during the 1st year of the pandemic: Pooled analysis of the International Citizen Project on COVID-19 (ICPCovid) surveys
by: Leonard Ngarka, et al.
Published: (2022)

Attitudes and perceptions towards epilepsy in an onchocerciasis-endemic region of Tanzania: a mixed approach to determine the magnitude and driving factors
by: Vivian P. Mushi, et al.
Published: (2024)

Safety of ivermectin during pregnancy
by: Stijn Van Hees, et al.
Published: (2020)

High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.
by: Bethany Levick, et al.
Published: (2017)

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
by: Evy Lenaerts, et al.
Published: (2018)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
by: Joseph N. F. Siewe, et al.
Published: (2019)

Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis.
by: Judith R Denery, et al.
Published: (2010)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
by: Gasim Abd-Elfarag, et al.
Published: (2018)

Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study
by: Michel Mandro, et al.
Published: (2018)

Violence and discrimination among Ugandan residents during the COVID-19 lockdown
by: Elizabeth Katana, et al.
Published: (2021)

Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study.
by: Luís-Jorge Amaral, et al.
Published: (2024)

Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis.
by: Christoph Kaiser, et al.
Published: (2013)

Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys.
by: Sébastien D S Pion, et al.
Published: (2009)

The World Health Organization road map for neglected tropical diseases 2021-2030: implications for onchocerciasis elimination programs
by: Melissa Krizia Vieri, et al.
Published: (2021)

Evidence for the exacerbation of lymphedema of geochemical origin, podoconiosis, by onchocerciasis
by: Fidelis Cho-Ngwa, et al.
Published: (2009)

Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach
by: Carabin Hélène, et al.
Published: (2003)

Investing in Onchocerciasis Control: Financial Management of the African Programme for Onchocerciasis Control (APOC).
by: Donald A P Bundy, et al.
Published: (2015)

Identification of the onchocerciasis vector in the Kakoi-Koda focus of the Democratic Republic of Congo.
by: Rory J Post, et al.
Published: (2022)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016)